Newcastle University
Toggle Main Menu
Toggle Search
Home
Browse
Latest
Stats
Policies
About
Home
Browse
Latest
Policies
About
ePrints
Browse by author
Browsing publications by
Dr Michael Grayling.
Newcastle Authors
Title
Year
Full text
Andrew Bryant
Dr Michael Grayling
Professor Dawn Craig
Professor Luke Vale
Residual Disease after Primary Surgical Treatment for Advanced Epithelial Ovarian Cancer, Part 2: Network Meta-analysis Incorporating Expert Elicitation to Adjust for Publication Bias
2023
Andrew Bryant
Eugenie Johnson
Dr Michael Grayling
Shaun Hiu
Dr Ahmed Elattar
et al.
Residual Disease Threshold After Primary Surgical Treatment for Advanced Epithelial Ovarian Cancer, Part 1: A Systematic Review and Network Meta-Analysis
2023
Samuel Sarkodie
Professor James Wason
Dr Michael Grayling
A hybrid approach to comparing parallel-group and stepped-wedge cluster-randomized trials with a continuous primary outcome when there is uncertainty in the intra-cluster correlation
2022
Luke Ouma
Dr Michael Grayling
Professor James Wason
Dr Haiyan Zheng
Bayesian modelling strategies for borrowing of information in randomised basket trials
2022
Dr Michael Grayling
Professor Rakesh Heer
Professor James Wason
Improving power in PSA response analyses of metastatic castration-resistant prostate cancer trials
2022
Dr Michael Grayling
Mind the gap: covariate constrained randomisation can protect against substantial power loss in parallel cluster randomised trials
2022
Andrew Bryant
Dr Michael Grayling
Shaun Hiu
Eugenie Johnson
Professor Luke Vale
et al.
Residual disease after primary surgery for advanced epithelial ovarian cancer: expert elicitation exercise to explore opinions about potential impact of publication bias in a planned systematic review and meta-analysis
2022
Dr Faye Williamson
Dr Michael Grayling
Professor James Wason
Subgroup analyses in randomized controlled trials frequently categorized continuous subgroup information
2022
Dr Michele Castelli
Dr Michael Grayling
The prevalence and social determinants of multimorbidity in South Africa
2022
Aritra Mukherjee
Professor James Wason
Dr Michael Grayling
When is a two-stage single-arm trial efficient? An evaluation of the impact of outcome delay
2022